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Abstract
Breast and cervix uteri are rare locations for Mycobacterium tuberculosis (MbT) infection and
MbT association to cervical cancer is more rare in European countries. This chapter analyses
two cases of rare locations of tuberculosis (TB) in young Romanian women. The first patient
presented a chronic primary TB breast abscess, non-pregnancy relatedwith periods of appar-
ent healing and repeated areolar fistula formation. In the second case, the unexpected discov-
ery of secondary TB endocervical granulomatous inflammation with caseous necrosis on a
radical hysterectomy specimen, performed after chemoradiotherapy for squamous non-
keratinizing cell carcinoma is presented. Worldwide incidence, risk factors, hypothetic mech-
anisms of primary/secondary breast and cervix uteri MbT infection, the association to high-
risk HPV, microbiological diagnosis difficulties, the differentials to pyogenic abscesses, other
chronic granulomas and breast cancer treatment issues are presented in the reviewed litera-
ture, focusing on thepeculiarities of these rare locations and complications. It is recalled an old
concept of “therapeutic antitubercular” test when all other assessments steps are usefulness.
Keywords: tuberculosis, breast abscess, cervical caseous granuloma, carcinoma
1. Introduction
Tuberculosis (TB) is an old disease, known since 5000BC, and contemporary professional and
scientific communities are challenged by the WHO’s “Global Tuberculosis Report 2017” showing
6.3 million new cases of TB in 2016, with about 16% expected to die due to TB by 2020.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
These data may be connected to the lack of an effective vaccine, and of sensitive and rapid
diagnostic tests, to the appearance of multidrug resistant strains of Mycobacterium tuberculosis
(MbT) [1, 2]. Low income, immunosuppressive disorders, worldwide travels and immigration
are associated to TB globalization [3]. Breast and uterine cervix are rare locations forMbT even
in TB endemic countries [1]. This chapter analyses two cases of rare locations of TB in young
women from Romania, a middle-income country. The first case is a chronic, non-pregnancy-
related primary breast abscess, with areolar fistula formation between periods of apparent
healing. The second case is an association of secondary endocervical tuberculosis to a squa-
mous cervical carcinoma in a young woman with a previous lung tuberculosis, without
activation during/after specific cervical cancer therapy. In Europe, there are few papers in the
form of case reports on breast or cervix uteri tuberculosis. Breast and cervix uteri tuberculosis
are uncommon diseases with non-specific clinical, imagistic and or cytological/histological
findings. Misdiagnosis or the diagnosis after many negative assessments for these rare TB
locations are common, because biopsy specimens are paucibacillary, and other investigations
such as microscopy and culture are frequently negative, as it is the PCR for MbT. MbT can
simulate cervical carcinoma in premenopause and postmenopause [4, 5] due to abnormal
vaginal bleeding at clinical presentation.
We intent to review and refresh the theories/hypothesis on the epidemiology, pathophysiology,
diagnosis and therapeutic issues on these rare MbT locations and complications. In countries
like Romania, where TB is non-endemic and the diagnosis for extra pulmonary tuberculosis
is a surprise, the golden standard of microbiological evidence of MbT is rare, even with the
new molecular techniques. It is reconsidered the “old concept of the therapeutic test” with
antitubercular drugs, which was proved to be active in pulmonary tuberculosis.
2. Cases presentation
First case: A 31 years old Caucasian woman, higher studies and salaried, married, nuligesta,
on combined oral contraceptives, no family or personal history of tuberculosis or known
exposure to a person with tuberculosis, no mammary surgery, is presenting in December 2014
with nipple retraction and inversion, skin redness and thickening, over a breast inflammatory
tumor of 2 x 1 cm size, in the internal upper quadrant of the right breast, freely mobile and a
fistula at areola level, with no axillary or cervical lymphadenopathy, and normal left breast.
The systemic examination is non-contributory, and no associated constitutional symptoms, as
fever, no weight and appetite loss are registered.
The patient had three previous similar episodes, since 2007, with a fistula of the right breast
abscess, sterile cultures for aerobic/anaerobic germs, and yeasts in the nipple purulent dis-
charge.
Routine hematological and biochemical investigations, and serum prolactin levels are normal,
HIV test is negative. Breast sonography reveals skin thickening, nipple retraction and dilated
terminal ducts and ill-defined thick-walled cystic mass of 2.9 cm diameter.
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The cytological examination after Giemsa stain from the fistula’s purulent discharge shows a
rich cellular smear, with many polymorphs background, lymphohistiocytic aggregates and
Langhans type multinuclear giant cells, fibrin debris and rare epithelial cells, which conducted
to the conclusion of a chronic breast inflammatory granuloma.
It is decided and incision-excision of the inflammatory mammary gland tissue was performed,
with large drainage of the remaining cavity, samples collection for pathology/microbiology
and no other unwanted events as shock or toxemia.
In January 2015, a new fistula occurred on the opposite on the opposite area of the right nipple,
with discharge of purulent material, without fever or other general symptoms, as she never
presented at each previous medical consultations (Figure 1).
The cultures for aerobic/anaerobic germs and yeasts are sterile, the pathological examination
discovers rare epithelial cells of squamous type, lymphocytes, plasma cells, histiocytes,
multinuclear giant cells of Langhans type and a multitude of blood vessels. The Ziehl Neelsen
stain for acid-fast bacilli and PCR for MbT from sample collected at excision biopsy are
negative (Figure 2(A, B)).
The chest X-ray examination is normal and the PPD skin test is 10 mm.
In March 2015, a 6 months antitubercular treatment (ATT) with three drugs was
recommended: isoniazid, rifampicin and ethambutol with intensive therapy for the first 3
months is administered. The follow up from May 2015 (after 2 months of intensive therapy)
shows remission of the fistulas, heal of the skin, the persistency of the nipple retraction and a
2 kg weight gain. The patient had a total 9 months ATT (Figure 3).
The final diagnosis is primary non-gestational breast tuberculosis abscess.
The second case: A 29 years merchandise by occupation, smoker of five cigarettes per day,
non-alcoholic, married since 10 years is presenting for repeated postcoital abnormal vaginal
bleeding and blood-stained discharge since 6 months. History: physiology: the menarche:
Figure 1. Photograph of the scar from slowly-healing post-incision/excision-drainage wound of the right breast, and the
new fistula on the opposite part of the right areola and purulent discharge.
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14 years; 2 full-term spontaneous deliveries; 1 abortion; pathology: pulmonary tuberculosis
(treated and considered healed in 2002); no surgical illness. LMP: August 20, 2008, immuno-
logical pregnancy and HIV tests: negative. General physical examination was essentially
normal; abdominal examination revealed no mass, no ascites, no hepatosplenomegaly and no
other abnormality.
Vaginal speculum examination: an irregular, cauliflower-like tumor of 4 cm in the largest size
on the anterior cervical ridge, spontaneously bleeding, and on touch; normal vaginal walls and
bilateral fornices.
Vaginal bimanual examination: anteverted uterus of normal shape, and volume, firm, mobile
and no adnexal mass.
Figure 2. Pathological images (A. Hematoxylin & Eosin, 40X; B. Hematoxylin & Eosin, 20X): Inflammatory granuloma-
tous lesions: Rich chronic inflammatory infiltrate, with many histiocytes (with epithelioid aspect) and frequent
multinuclear giant cells Langhans-type. Collection of Degeratu Daniela, “Dr I. Cantacuzino” Laboratory of Pathology.
Figure 3. Photograph of the right breast after two months of intense active antitubercular treatment. Patient in recumbent
position with healed wound, without sinuses of the areola, and inverted nipple.
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Per-rectal examination: smooth rectal mucosa, and freely mobile, no induration or nodularity
of both parametrials.
Pap smear: epithelioid-like cell clusters with atypia. Colposcopic examination increased vas-
cularity on the posterior cervical ridge, acetowhite on the anterior cervical ridge, with negative
iodine stain with precise contour around the previously described cauliflower-like tumor.
Provisional diagnosis of carcinoma cervix stage I B was kept, and after preliminary investiga-
tions, patient was posted for multiple cervical biopsies—the tumor and from other four cardi-
nal points in the vicinity.
The histopathological diagnosis came out to be squamous non-keratinizing cell carcinoma
(Figure 4), and the specific tests for viral infection had revealed the presence of genotype 33 HPV.
Hematological test: low degree anemia (Hb: 11.0 mg/dL, Ht; 34%), leukocytosis and
thrombocytosis.
Biochemical and coagulation tests: normal.
Chest radiography showed fibrous and fibro-nodular sequelae of pulmonary tuberculosis.
After 4 weeks of radiotherapy (tele-radiation and 2 cures of brachytherapy) plus chemother-
apy (cisplatin), the patient is proposed for surgery, which is accepted and it is done a
Wertheim’s radical hysterectomy with bilateral pelvic node dissection. The post-surgery path-
ological examination showed a cervix with large areas of ulceration, polymorph inflammatory
infiltrate and multinuclear giant cells of foreign body type, micro-calcifications and small
islands of squamous non-keratinizing cancer cells. The endocervix presents a granulomatous
inflammation with caseous necrosis and Langhans multinuclear giant cells. The vaginal part
and the lateral part of the cervix have no neoplastic invasion. The endometrium is atrophic, the
ovaries have albicans bodies, the tubes have hypoplastic mucosa,and the examination of 10
lymphnodes shows their reactive aspect, lipo-dystrophy and micro-calcifications.
PCR for MbT was performed on archived tissue (formalin-fixed paraffin embedded uterine
tissue) following detection of cervical TB by pathology, was positive in the cervix. The patient
Figure 4. Two confluent epithelioid caseous granulomas with Langhans-type gint multinuclear cells and lymphocytic
inflammatory infiltrate at the periphery, HE stain, 10 x. Collection of Degeratu Daniela, “Dr I. Cantacuzino” Laboratory of
Pathology.
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has a normal evolution post-radio, chemotherapy and post-surgery, without any reactivation
of the pulmonary tuberculosis.
3. Epidemiology: risk factors
3.1. Epidemiology of breast tuberculosis
Breast TB was first described in a very young woman by Sir Astley Cooper in 1829 as
“scrofulous swelling of the bosom”, and the location of MbT in the cervix uteri was first
described 2 years later by Renaud (1831). Extrapulmonary TB was reported in nearly 18% of
cases in USA [6], and TB location in the breasts is extremely rare in Western populations from
0.025 to 0.1% of all surgically treated breast diseases. In the last 20 years, the Southern
European countries such as Greece, Turkey, Italy and Spain reported rare such cases, and
0.64–3.59% of all mammary treatable conditions are in developing countries from Asia [7],
where the overall incidence of histological confirmed breast TB is 0.4% per year [8]. In India,
the incidence of breast TB is five times less common than carcinoma of the breast [8]. There are
described fluctuations in the incidence of generally breast TB, with the highest incidence in
Southern Turkey in 2007 [10], and in the last 8 years (Table 1) the reported cases with primary
breast TB have an increasing incidence all over the world, as it is the Romanian case, which
had the first episode in 2007. Mammary involvement is nearly equal in frequency in the right
and left (40.0 vs. 44.0%) [10], bilateral disease is rare [11, 12], as it is the infra-mammary
location of tuberculosis [13]. Breast tuberculosis is affecting women in the reproductive age,
Continent Number of cases since the year 2000 (00)
00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16
Europe 1
It
0 0 1
Gr
0 1
T
1
T
1
Ch
0 3
T
0 0 0 0 0 1
R
0
Africa 0 1
Mo
1
Mo
0 0 0 0 0 0 0 0 0 1
Mo
0 0 0 0
Asia 8
In
1
In
0 0 0 35
In
0 1
In
0 2
In
Tw
3
Ir
In
8
In
2
In
8
Ir
In
0 0
North America 0 0 0 0 0 0 0 0 0 0 0 0 1
Mx
0 0 0 1
US
South America 0 0 3
Br
0 0 1
Br
0 0 0 1
Br
0 0 0 1
Co
0 0 0
Australia
New Zeeland
0 0 0 0 0 0 38 0 0 0 0 0 0 0 0 0 0
It, Italy; Gr, Greece; T, Turkey; Ch, China; R, Romania; Mo, Morocco; In, India; Tw, Taiwan; Ir, Iran; Br, Brasil; Mx, Mexico;
Co, Columbia; US, United States of America.
Table 1. Annual worldwide published cases with primary breast tuberculosis (last 16 years medical literature - Google
scholar, Medline, web of science).
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21–30 years, predominantly, a case being reported during pregnancy [14], and rarely in prepu-
bescent [15] and elderly postmenopausal women [16], the last category being more affected in
the early twentieth century, and in the last years it is discovered in women and men [17, 18].
None of the recognized risk factors (multiparity, lactation, trauma, past history of suppurative
mastitis, breast surgery/breast reconstruction [19, 20], silicon breast introduction or AIDS [21]
was present in the Romanian reported case.
3.2. Epidemiology of cervix uteri tuberculosis
In developing countries like India, TB is a major socioeconomic burden, afflicting 14 million
people mostly in the reproductive age group (15–45 years). Regarding the genital tract,
fallopian tubes are involved in almost all the cases of pelvic tuberculosis, endometrium in 50–
60% and ovaries in 20–30% [22]. Cervical tuberculosis accounts for 0.1–0.65% of all cases of the
disease and 5–24% of genital tract [23].
4. Pathophysiology
4.1. Pathophysiology of breast tuberculosis
The breast was considered an organ that offers resistance to the survival and multiplication of
the tubercle bacillus [24], like other organs such as spleen, skeletal muscle or cervix uteri, and
this property is one of the reasons for the uncommon diagnosis of breast TB, and in countries
like India it is supposed that the breast TB is confused to carcinoma [25], or to a pyogenic
breast abscess [26], or to other diseases [27], tubercular mastitis being a “great masquerader”
[28]. In contrast to this quality, when breast is infected withMbT, it was proved that BRCA 1/2
network is suppressed during infection suggesting that breast cell proliferation suppression is
a feature of Koch bacilli survival [29].
Breast TB is described to be primary or isolated, and secondary. The primary breast TB is
appreciated when the breast infection is the only manifestation of the disease, no demonstrable
tuberculous focus exists elsewhere in the body [30], and the infection is through abrasions or
through the openings of the ducts in the nipple. Primary breast TB is rare in comparison to
secondary to lung or extrapulmonary, and the authors consider that the Romanian case is
among primary breast tuberculosis. The secondary type is appreciated when a pre-existing
lesion is located elsewhere in the body. Secondary MbT can spread by three routes such as
hematogenous, lymphatic or directly from the primary location such as lung, pleura, ribs,
mediastinum and articular lesions. It is supposed that the patient had acquired theMbTduring
a plain long distance travel, some previous years ago, when she claimed the first episode of
breast inflammation; extensive travels seem to be responsible for tuberculosis globalization,
statement common to others’ physicians [3], which is an explanation for a primary men’s
breast tuberculosis, as it the case of a 44 years old Lithuanian man living in UK [18]. In
countries where TB is endemic, young lactating women are more prone to develop breast
tuberculosis, being described an incidence that can vary in the limits of 7–33% [31–33]. All
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types of Mycobacterium spp., and other types of antigens or foreign bodies, as milk during
pregnancy or lactational period, are met by a vigorous cell-mediated hypersensitivity reaction
involving macrophages, epithelioid and giant cells, Th1 lymphocytes, and their cytokines,
which are activated and are developing the granulomas [34].
In Romania, like in countries with endemic tuberculosis as India, Pakistan, China, Iran and
Korea, tubercular infection is seen more frequent secondary to a tubercular focus such as
lungs, pleura or lymph nodes, which very frequently actually may not be detected clinical or
radiological [26]. The breast infection is acquired usually from lungs by many routes (hema-
togenous, lymphatic via tracheobronchial, paratracheal, mediastinal lymph trunks or internal
mammary nodes), by spread from contiguous structures and by ductal infection [8]. MbT is
affecting differently breast structures, according to route of contamination: the epithelium of
the ducts (primary) or of the lobules (secondary) with loss of acinar structures; and the entire
epithelial lining of the lobules is destroyed, caseating necrosis appearing in the center of the
lesion, and the destructive mechanisms are progressing and involving the skin, which may
ulcerate and create fistula/sinuses; in other cases, specially in elder women, the mechanisms of
repair/restoration are developing excessive dense fibrous tissue.
4.2. Pathophysiology of cervix uteri tuberculosis: Hypothesis on the association to cervical
cancer
Pelvic organs are infected from a primary focus, elsewhere in the body, most commonly from
lungs, by hematogenous spread. The cervix may be infected, as a part of this process, by
lymphatic dissemination from the infected tube, or by direct extension from the endometrium.
It is discussed a cervical infection from the sexual partner/partners with tuberculous epididy-
mitis, being discussed the increased risk when there are multiple sexual male partners, espe-
cially in China [35]. It is discussed a relative immunity of the cervix to MbT as it was shown
previously for other organs, which is probably connected to the inability of the bacillus to
penetrate the squamous epithelium of portio vaginalis, and to cervical mucus resistance, but in
rare cases, cervical TB may be a primary infection, MbT being introduced by a partner with
tuberculous epididymitis or other genitourinary disease [36], but the sexual partner of the
reported patient was negative for pulmonary TB. It was suggested the role of the sputum used
as a sexual lubricant [22].
In the nineteenth century, it was a controversy as whether tuberculosis and cancer can coexist
in the same organ; Carl von Rokitansky (1855) was the first to propose the view that there is a
definite antagonism between the two, meaning that tuberculosis and cancer cannot be present
in the same organ, but after the influences of Votta J Paul work and through his own further
experience, Rokitansky later changed his previous generally accepted view, and admitted that
tuberculosis and carcinoma can coexist, but that this coexistence is rather rare. The Romanian
report on this pathological association is done for its rarity in Europe, and to the best of
authors’ knowledge, in the last 45–50 years, two similar cases in Romania (Iaşi) by Luchian
et al. [37] and one case in Poland [38] are described. The question is whether tuberculosis is
before cancer, or the presence of the viral infection made possible the secondary location of the
MbT. The pathological exams of the reported case did not revealed extensive granulomatous
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reaction, or cancer metastases in the endometrium, tubes, ovaries and lymph nodes. Since
many years from the first description of the association of these two life-threatening patholo-
gies, host response as the basic mechanism of specific defense against infection and tumor
factors that enable such a response are also discussed since long time [39], being not
completely known/understood, they may benefit from the host’s previously compromised
immunity:MbT and HPV can potentate each other.
The MbT is a facultative intracellular parasite that grows well in non-activated macrophages.
When large numbers of these bacilli have grown intracellularly within such macrophages, a
cytotoxic immune response, herein called tissue-damaging delayed-type hypersensitivity kills
the macrophages, forming the caseous center of the tubercle, where the tubercle is surviving;
such a delayed-type hypersensitivity was first described for the pulmonary tuberculosis [40],
and this patient have suffered from pulmonary tuberculosis 7 years earlier. The progression of
cervical dysplasias to invasive, lethal cervical cancers has been attributed to diverse factors
such as immune, hormonal, and nutritional status, or co-infection with other sexually trans-
mitted agents, supporting data being equivocal [41].
The contemporary professional societies are sure on primary immune defense system defi-
ciency or incapacities to some infections, bacterial and viral, which were demonstrated in the
systemic circulation and in some bodies locations – in the cervix uteri or in the breast. In North
America [42], Western Europe [43, 44] and recently in China [45], it was proved the shifted
balance between T helper 1 (Th1)-type and Th2-type cytokines in cervical dysplasia [42, 46],
the involvement and increase of invariant natural killer T (iNKT) cells (which are in small
number in condyloma acuminatum, in mild and moderate dysplasias [47]), and the cytokines
production from cervical keratinotytes [48] the main targets of HPV infection as the stratified
epithelium cells, and the main source of cytokines [49], as type I interferon (IFN)-γ, tumoral
necrosis factor (TNF)-α, transforming growth factor (TGF)-α, interleukin-1 (Il-1), interleukin-6
(Il-6), interleukin 8 (Il-8) expressions are involved in immune system modulation (all of them
being parts of innate immune system), in the evolution from persistent high-risk HPV-infected
cells to the development of high-grade cervical intraepithelial neoplasia and cervical cancer,
because the keratinocytes cannot destroy the fact high-risk HPV, and that may work also on
MbT infection evolution, and complications. Parallel to these conditions, it is the individual
cellular system of defense [50], involved in early phases of infection [51, 52]. Flow cytometry is
revealing an increased level of CD3+ T, CD + 4 cells [53, 54] among both epithelium and
stromal layers of the cervical tissues, contributing to the suppression of local immunity. In
conjunction to these details is the presence of the population of monocytes/macrophages in the
endocervix, with increasing number in cervical high-grade lesions with the parallel decrease in
Langerhans cells, in contrary to what occurs in non-infected tissues [55]. All these facts con-
tribute to the escape of HPV to tissue innate and acquired immune system, which is also
influenced by the viral epitopes E6 and E7 [56], and evolution from less invasive to more
advanced invasive cervical HPV-induced carcinoma is associated to a higher number of T and
B lymphocytes, macrophages and induced nitric oxide synthase-expressing cells in the
peritumoral stroma, so cell migration being proportional to the progression of the lesion [54].
Some studies show that these high number of inflammatory cells and compounds may open
the way to bacterial infections, being additional mediators [57].
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Insertional mutagenesis by HPV is another proposed tumor-promoting mechanism, but recent
studies have not supported this hypothesis [58]. No common, recurring genetic alterations that
cooperate with HPV to promote cervical cancer progression have been identified since Harald
Zur Hausen first identified HPV as the causal transmissible agent of cervical cancer nearly 40
years ago [59]. To the pressing question to the biological basis of cervical cancer progression
which is to be resolved since long time, the discover of the loss of a major tumor supressor
LkB1 [60, 61] or somatically acquired mutations in this tumor supressor LKB1 [62], which is
considered to be similar to p53. When LKB1 deficiency/mutations, a primary cervical tumor
confined to the cervix at the time of diagnosis has a bad prognosis: early metastasis and patient
death, after the initial diagnosis despite aggressive therapy including radiation treatment.
These abnormalities were first discovered in connection to Peutz-Jeghers Syndrome [63] and
pulmonary cancer [64]. The MbT was proved to reduce host’s immunity to high-risk HPV
types for cervical cancer. The Chinese study “Shanxi Province Cervical Cancer Screening Study
I” [36] showed an increasing magnitude of effect of MbTwith increasing severity of disease in
an isolated women population from rural China, as is demonstrated by the increasing odds
ratios from 1.68 for HPV positivity to 1.75 for persistent HPV and then 2.08 for CIN3+.
Associated to these findings, it was showed that TB and cervical inflammation were diagnosed
in 1% of the women, and associated with 90% higher odds of oncogenic HPV infection and
113% higher odds of persistent HPV infection. The authors of the “Shanxi Province Cervical
Cancer Screening Study I” are considering that their results are consistent with the novel
hypothesis that TB may provide an immunological profile that is associated with an increased
susceptibility to HPV infection. In conjunction to this hypothesis, we can speculate like that
MbT is associated to the loss/mutations in LKB1 tumor suppressor, because persistence of small
islands of squamous non-keratinizing cancer cells after radiation and chemotherapies.
5. Diagnosis
Regarding the diagnosis, one must consider the clinical presentation, physical examination,
laboratory results, specially the microbiological ones and imagistic tools, and after the difficul-
ties of the Romanian first published case of breast tubercular abscess on must reconsider an old
concept of diagnosis—the “therapeutic” test.
5.1. Clinical presentation: physical examinations
5.1.1. Clinical presentation of breast TB
Clinical presentation of breast TB is variable regarding symptoms/signs: swelling of the breast
48.1% [65]; painless hard lump in approximately 60% cases [66], or pain is revealed as the first
complain of some patients [67, 68] or up to 18.5% of cases [65]; rarely are recorded multiple
lumps, the lump being with irregular borders, sometimes with skin fixation or to the underly-
ing muscle or even chest wall, clinical findings imposing differential to breast carcinoma [69],
situation which is much more suggested by the presence of an isolated breast mass, sometimes
skin fixated “peau d’orange” sign, and without an associated sinus tract; abscess, unique or
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multiples; skin thickening; and skin sinus/fistula/multiple discharge sinuses [70], nipple retrac-
tion or inversion, nipple hyperpigmentation or focal discoloration –when the disease is long
time duration [69], breast shape and sizes change, axillary lymphadenopathy (axillary lymph
nodes are found in one-third of cases with breast TB [33]. Constitutional symptoms as fever,
weight loss, night sweats or a failing of general health are infrequently encountered [71, 72].
5.1.2. Clinical diagnosis of cervix uteri tuberculosis
Irregular vaginal and postcoital bleeding with different aspects could occur at the cervix
speculum examination such as exophytic-cauliflower aspect, tumoral-granulomatous, ulcera-
tive and polypoid endocervical [73]. In many countries, even where tuberculosis is endemic,
the majority of cases remain asymptomatic, but infected, and are discovered incidentally or
remain undiscovered [22, 74]. Cervical examination of cases with cervical tuberculosis is
normal in 90% cases, and the rest presents non-specific macroscopic changes, ulcerative/hyper-
trophic nodular lesions like proliferative cauliflower growth or fistulas/sinuses, or friable
papillary growth covering almost the entire ectocervix. All these aspects may simulate inva-
sive cervical cancer, or a miliary appearance [75–77]. There are reported cases with entire
genital tract involvement, with myometrial alterations [78, 79], and association with tubercu-
losis of vulva and vagina [80].
5.2. Laboratory assessment
Current hematological and biochemical analysis are minimally influenced in cases with these
MbT locations. It is cited a high level of white blood cells, and of ESV [77].
5.2.1. Bacteriological diagnosis
The golden standard for TB diagnosis is to detect acid-fast bacilli (AFB) in the infected tissue,
but it is well known how difficult is the Ziehl-Neelsen stain or the cultures for BK to become
positive [67, 72, 81], because the necessity of a high number MbT in the smear (more than
10,000 bacilli/mL), and the slow growth of all mycobacterial species, including MbT, fact that
partially explains the delay of TB diagnosis. It was recommended scanning with high-power
oil immersion because these diagnosis difficulties, but the practice proved that scanning with a
X 40 objective should suffice in most cases. There were proposed alternative stains to the
conventional Ziehl-Neelsen stain, such as auramine/auramine-rhodamine using fluorescence
technique [82], which in association to a higher power examination (x 600) may have better
detection for MbT [83].
It is known that biopsy specimens that are cultured on Löwenstein-Jensen medium at room
temperature yield pigmented mycobacterial colonies in 2–4 weeks. In the literature of bacteri-
ology, it is very important the place for sampling, and leveling that may affect the sensitivity of
a stain in the detection of rare organisms asMycobacterium spp. or fungi. On the other side, for a
better discovery forMbT, it is recommended to examine at least two blocks of biopsy instead of
one [84]. In India, it is reported that are possible positive cultures of nipple discharge for
Staphylococcus aureus associated with positivity for MbT [85].
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Actually many infections are detected by immunological assays proving the host competence,
but for TB this aim is still a future desire; a very recently study of North American Universities’
Microbiology and Pathology Laboratories [86] have confirmed the limitations of serodiagnosis
for active tuberculosis, including poor sensitivity and increased reactivity with non-tuberculous
mycobacterium-positive patients.
5.2.1.1. Bacteriological diagnosis of breast tuberculosis
The molecular diagnosis from clinical specimens is the aim of modern diagnosis of MbT, since
many years, and this may be accomplished by nuclear acid amplification (NAA). The used
methods allow the detection of mycobacterial DNA or RNA directly from the specimens,
before the culture results are available [87]. Food and Drug Administration had accepted since
the year 2000, two types of NAA, which were initially used for pulmonary tuberculosis, and
later in extrapulmonary cases. The NAA is usually recommended when the smear evaluation
is negative for AFB, and when clinical suspicion is very high, or when TB is endemic, but there
are controversies on the specificity, sensitivity of the methods regarding the origin of specimen
from respiratory tract or other sites [88]. The recommended tests are the enhanced MbT Direct
Test (E-MTD; Gen-Probe, San Diego, CA) and AmplicorMbT Test (Amplicor; Roche Diagnostic
Systems, Inc., Branchburg, NJ), and associated to these tests there were many studies about
each value, specially for differential to granulomatous mastitis [12, 83, 89] or for the value of
polymerase chain reaction (PCR) for real time MbT to compare to formalin-fixed, paraffin-
embedded histologic specimens [90].
The real-time PCR for MbT on paraffin-embedded tissue is available with a high specificity of
99%, but low sensitivity of 65% for breast tissue in contrast to other types of specimens such as
cerebral spinal fluid, urine and bronchoalveolar lavage, where sensitivity of more than 90% is
reported, with comparable specificity [91, 92].
In the Romanian case, the molecular test—PCR for MbT on paraffin-embedded breast tissue
was negative, and there are some researches [83, 93, 94] sustaining that molecular tests are not
always relevant for the diagnosis of TB in smear-negative specimens. It is appreciated that real-
time PCR for MbT is useful if positive, and confirms the presence of MbT, but if negative does
not rule out the possibility of an infection [83]. Breast TB is paucibacillary and consequently
tests such as microscopy, culture and NAA tests such as PCR techniques do not have the same
diagnostic utility as they do in pulmonary tuberculosis [95]. There are some explanations for
the negativity of the described tests for BK identification. One old explanation [84] is that the
microorganisms have been killed and/or removed by the inflammatory process. Other expla-
nation for PCR negativity is the existence of non-tuberculous infections such as Corynebacterium
spp. [96], or non-tuberculous mycobacterium, which are now more common than tuberculosis in
Western countries, and therefore would not be detected by this assay.
5.2.1.2. Bacteriological diagnosis in cervical tuberculosis
The demonstration of the presence of MbT in the cervix uteri with the Ziehl-Neelsen staining
was proved to be difficult in many reported cases all over the world, even in India and China
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[97]. In the Romanian case, MbT presence in the endocervix was confirmed by PCR for MbT
performed on archived tissue (formalin-fixed paraffin-embedded uterine tissue).
5.3. Cytological diagnosis
5.3.1. Cytological diagnosis of breast tuberculosis
Actually fine needle aspiration cytology (FNAC) is considered a minimally invasive diagnosis
method for breast pathology [98], including TB, because is revealing chronic granulomatous
inflammation with caseating necrosis, presence of Langhans giant cell, and lymphocytic aggre-
gates [99–101], but some studies are showing that in one quarter of cases FNAC is negative for
breast tuberculosis diagnosis [71], because tissue samples collected at FNAC are not usually
adequate for evaluation, or because caseating necrosis can be absent on the specimen. The
absence of necrosis on breast specimen from FNAC does not exclude tuberculosis, which is
sustained by other histological abnormalities [102]. In these situations, the next step for the
diagnosis of mammary TB is the pathologic evaluation of specimens collected at open surgical
biopsy [71], as it was done in the Romanian case, after the evaluation of the smear from fistula
discharge.
5.3.2. Cytological diagnosis of cervix uteri tuberculosis
The Pap smear, a non-invasive procedure, may help in the diagnosis by the discover of
epithelioid and multinucleated histiocytic cells, described since many years ago and rediscuss
actually [103–105], fact that prompts further investigation. The epithelioid cells are elongated
cells with pale eosinophilic cytoplasm, indistinct cell borders having large oval/elongated
nuclei with a delicate chromatin pattern in singles/clusters. Multinucleated histiocytic cells,
typical of Langhan’s cells type, have large number of delicate, often ovoid nuclei, some
overlapping, arranged peripherally and often in horseshoe fashion. The presence of those
multinucleated histiocytic giant cells may help to differentials to herpes virus infection—the
cells have epithelial origin, but lower number of nuclei, and show characteristic crowding/
molding without overlapping with eosinophilic inclusion in nuclei and cytoplasm, and also in
post radiotherapy of postmenopausal women smears, where the cells have bad outline, and
may contain some phagocytosed debris with radiation-induced changes [104]. In countries
with endemic tuberculosis, it is appreciated that the Papanicolaou smear is helping very much
the staff, the Ziehl-Neelsen stain of cervical smear, and fluorescent technique and culture are
confirming later [105]. The Romanian woman was not postmenopausal, a viral infection with
high-risk HPV was clearly demonstrated, by genotyping of the cervix after surgery, but these
type of cells were absent in the smear.
5.4. Pathological diagnosis ofMbT infection
5.4.1. Pathological diagnosis in breast MbT infection
There are known two pathological classifications of breast tuberculosis: an old one—McKeown
and Wilkinson [106] cited by Bahoroon [107], and a recent one—Tewari and Shukla [7].
Breast and Cervix Uteri: Rare Locations for Mycobacterium Tuberculosis Infections…
http://dx.doi.org/10.5772/intechopen.75044
145
McKeown and Wilkinson [106] had classified breast tuberculosis into five pathological varie-
ties: (1) nodular—the most common variety presenting as a localized mass, with extensive
caseation, and little fibrosis; (2) diffuse or disseminated—second most common variety, involv-
ing the entire breast with multiple intercommunicating foci of tubercles within the breast,
which caseate leading to ulceration and discharging sinuses; (3) sclerosing—extensive fibrosis
rather than caseation is present, suppuration is rare, the entire breast is hard, the nipple is
retracted/inverted, category which is often mistaken for breast carcinoma; (4) tuberculous
mastitis obliterans, characterized by duct infection producing proliferation of the lining epi-
thelium, and marked epithelial and periductal fibrosis; and occlusion of the ducts, with
appearance of cystic spaces, and all these resemble “cystic mastitis” and (5) acute miliary
tuberculous mastitis, which occurs as a part of generalized miliary tuberculosis. The last two
entities have only historical importance, being rarely described in the recent medical literature.
The Indian pathologists [108] have introduced a new pathological classification of breast
tuberculosis, with three categories: (1) nodulo-caseous tubercular mastitis; (2) disseminated/
confluent tubercular mastitis and (3) tubercular breast abscess.
There are some controversial discussions about the “granulomatous mastitis”, diagnosed
during childbearing period, usually in parous women, in early 1930s, which are frequently
misdiagnosed as tuberculosis or carcinoma [108], with negative culture for MbT, and with
cytological and immunocytochemical findings definitely for differential diagnosis from breast
tuberculosis at fine needle aspiration cytology [109] or at open surgery. The pathological
changes induced byMbT in breast make the differences to other breast pathology, “idiopathic
granulomatous mastitis”, which is also a “masquerader” [25, 28]. Tuberculous mastitis is often
considered a form of “granulomatous mastitis” secondary to breast MbT infection, and some
authors reserve the term of “granulomatous mastitis” to “idiopathic granulomatous mastitis”,
a chronic breast inflammatory entity [110]. Granuloma is a defense mechanism against anti-
gens, which stay in many organs without inactivation. The granulomatous lesions are classi-
fied into infectious, vasculitis, immunological, chemicals and neoplasia [35], or the recent
classification is more simple: infectious and non-infectious granulomas, with the prove from
new studies that pathogenic microorganism are suspected to be a cause of granuloma in non-
inflammatory diseases [111].
The etiology of “granulomatous mastitis” is unclear, being postulated, and sometimes proved,
the autoimmune factors [112], sarcoidosis, fat necrosis, undetected organisms (as blastomyco-
sis, actinomycosis, cryptococcosis, histoplasmosis, filarial infection and corynebacterium),
Wegener’s granulomatosis, reaction to childbirth, and use of oral contraceptives, ductular
ectasis [113] the last two factors are present in the reported case. “Granulomatous mastitis”
was the first diagnosis in authors’mind at the beginning of investigations, and this is partially
an explanation of the delay in diagnosis, and late specific antitubercular treatment, as in other
cases from literature in the last years [12]. These breast pathologies – tuberculosis and “idio-
pathic” granulomatous mastitis are considered “masquerader” [28] or “imitator” [89].
There are described some pathological characteristics [107, 114, 115], which make the differen-
tiation between the “idiopathic “granulomatous mastitis”—first described by Kessler and
Wolloc [113], and breast TB. TB is affecting all breast structures (lobules, ducts, fat; some
pathologists consider that ducts are specially affected), and the tubercular granulomas are
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associated to caseating necrosis which makes the name of “caseating granulomas”, and the
difference from “idiopathic “granulomatous mastitis [107, 116], which was named “lobular
non caseous granuloma” (Table 2). The isolation of MbT in the central necrosis increases the
sensitivity of the diagnosis.
There are mentioned some other types of “necrositing granulomas” in which infections-
inflammation are frequently associated, and are proved with special stains (as Ziehl-Neelsen
or Grocott Methamine Silver), and/or by cultures, and other granulomas with infection-
inflammatory aspect, but without associated infections as eosinophylic necrosis or basophilic
necrosis [83], as is Wegener’s granulomatosis, and less commonly rheumatoid nodule, necro-
tizing sarcoid granulomatosis, infarct and lymphomatoid granulomatosis [83]. The granulo-
mas with eosinophilic necrosis have regular rounded contour, the rim being formed of
epithelioid histiocytes with multinucleated giant cells, and the center may have coagulative
type of necrosis, which is like an infarct. The Wegener’s granulomatosis is characterized by
‘dirty’ basophilic necrosis with irregular geographic necrosis; the necrosis is rimmed by
palisading histiocytes and scattered multinucleated giant cells, with hyperchromatic nuclei
and peripheral to the necrosis is the necrotizing vasculitis in vessels. The vessels display
transmural fibrinoid necrosis, and the necrosis of the media with admixed necrotic neutro-
phils, which contributes to the diagnosis with true necrotizing vasculitis. The granuloma of the
Romanian case has multiple normal vessels. The parenchymal necrosis of the necrotizing
Characteristic “Idiopathic” granulomatous mastitis Tubercular mastitis
Macroscopic characteristic
Isolated or multiple
breast masses
Common Common
Multiple sinuses or
fistulas
Absent Present
Abscess Common Uncommon
Focal discoloration of
areola
Absent Present
Microscopic characteristic
Structure affected Mammary lobules from one breast, rarely
bilateral
All mammary structures: ducts, lobules, fat,
commonly bilateral
Type of lesion Granulomas of the lobules Granulomas of all mammary structures
Histological
components of breast’s
granulomas
Epithelioid histiocytes, Langhans giant cells,
lymphocytes, plasma cells, and occasionally
eosinophils
Epithelioid histiocytes, Langhans giant cells,
lymphocytes, rare plasma cells, and
eosinophils
Foamy cells Absent Present
Caseating necrosis Absent Present
Fibrosis Present Present
Fat necrosis Present Present
Table 2. Macroscopic and microscopic characteristics of “idiopathic” granulomatous mastitis and tubercular mastitis
(modified from Akcan et al. [114]; Baslaim et al. [115]; Bahoroon [107]; Lacambra et al. [109]).
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sarcoid granulomatosis is variable, usually eosinophilic but can be irregular and basophilic,
mimicking Wegener’s granulomatosis.
The pathological characteristics of the “idiopathic” lobular non-caseating granulomas and of
tuberculosis caseating granuloma of the breast are listed in Table 2, and it is considered [83]
that no single histological feature may distinguish infectious necrotizing granulomas from
other specific disorder as Wegener’s granulomatosis or sarcoidosis, being necessary a combi-
nation of multiple pathological features to establish the specific diagnosis.
The first reported case of this chapter is a primary breast TB, with no personal history, or other
focus on the systemic physical/radiological examinations for TB. The diagnosis of breast TB
must follow the general principles: clinical and laboratory. The clinical presentation of breast
TB is variable regarding symptoms/signs: swelling of the breast—48.1% [10]; painless hard
lump—approximately 60% cases, or pain is revealed as the first complain of some patients [67,
68] or up to 18.5% of cases [10]; rarely are recorded multiple lumps, with irregular borders,
sometimes with skin fixation or areola fixation, or to the underlying muscle or even chest wall,
clinical findings imposing differential to breast carcinoma [69], situation which is much more
suggested by the presence of an isolated breast mass, sometimes skin fixated-“peau d’orange”
sign, and without an associated sinus tract; ulceration of areola [117], or of the skin covering
the mammary gland [118]; abscess, unique or multiples [85]; skin thickening and skin sinus/
fistula/multiple discharge sinuses [70], nipple retraction or inversion, nipple hyperpig-
mentation or focal discoloration—when the disease is long time duration [69], or distruction
of nipple-areola region [19], breast shape and sizes are changed, axillary lymphadenopathy
(axillary lymph nodes are found in one-third of cases with breast TB). Constitutional symp-
toms as fever, weight loss, night sweats or a failing of general health are infrequently encoun-
tered [71, 72].
5.4.2. Pathological diagnosis of cervical tuberculosis
The cervical tuberculosis diagnosis is commonly established by the Papanicolaou smear
without any dysplasia, positivity for acid-fast bacilli, and the cervical biopsy (punch, loop
excision biopsy) showing granulomatous inflammation with caseous necrosis, facts that
were absent in the Romanian case. The presence of the viral infection is clearly proved by
genotyping of the cervix after surgery. The endocervical curettage which has the possibility
to diagnose associated endocervical tuberculosis was not done, because they believe that
exocervical lesion was the only cause of abnormal bleeding. The pulmonary tuberculosis was
7 years previously registered, and the genital location was diagnosed in the endocervical
glands, on the specimen collected at hysterectomy—after radiotherapy and chemotherapy.
The presence of the endocervical tubercle bacillus was indirectly diagnosed by the patho-
logic examination the presence of caseous necrosis and Langhans multinuclear giant cells,
and by PCR for MbT. The diagnosis of TB depends also upon the isolation of the MbT on
microscopy, and culture, and by the PCR. Culture of MbT and acid-fast staining was not
done, the cervical granulomas were noted at pathological examination after surgery, on a
formalin-fixed specimen. The presence of characteristic, typical caseous granuloma was
appreciated sufficient to make the diagnosis [77, 119], but many researchers consider that it
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is very important to distinguish between the granulomatous reaction and tuberculosis by
more specific methods [120]. The presence of stroma caseous necrosis was sufficient for the
positive diagnosis of cervical TB in the Romanian authors’ opinion. The granuloma diagno-
sis is a microscopic diagnosis. The microscopy of the cervical specimen after radical hyster-
ectomy reveals an aggregate of immune cells, appearing as epithelioid macrophages, and
if a foreign body or a parasite is not observed inside the granuloma, stains for acid-fast
bacilli, and fungi are ordered as mycobacteria and fungi (such as Cryptococcus, Blastomyces,
Coccidioides and Aspergillus can be seen on hematoxyline-eosine, preferentially in the area
of necrosis rather than the surrounding viable area) are frequently the cause of this type
of inflammation [31]. In cases with samples fixed in formalin the detection of the infectious
agent is recommended to be done by molecular analysis, PCR for MbT in the Romanian
case [91, 118].
5.5. Imaging diagnosis of rare tuberculosis locations
5.5.1. Radiological imaging of breast tuberculosis
Radiological imaging of breast tuberculosis is appreciated not to be diagnostic, and the
described mammographic images are in connection to three patterns of breast tuberculosis:
nodular, disseminated and sclerosing patterns [121]. Some radiological characteristics are
common for all patterns, like the change in shape, and outline of the breast mass—seen in the
standard views, the reduction in size of the affected breast, skin thickening, nipple retraction
and ill-defined breast mass [122]. In previous radiological studies, the skin bulge and sinus
tract sign, which connects the breast density to a localized skin thickening or to the skin bulge
are the radiological features strongly suggestive for tubercular breast abscess [66].
In the Romanian case, the mammography was not recommended, because authors thinking
was dominated by a chronic inflammation with repeated episodes of recurrence, as a granulo-
matous mastitis or a plasma cell mastitis.
Some clinicians [123] recommend computed tomography scan, when are doubtful cases, for
the differentiation of primary and secondary lesions, to evaluate accompanying pulmonary
disease, if it is present or to detect the continuity of the breast lesions with the thoracic wall or
pleura, and associated lesions of the lungs.
5.5.2. Ultrasonography for breast tuberculosis
In the literature, there are controversies about the value of ultrasonography for breast TB
diagnosis. On one side, it is mentioned no specificity of the ultrasound examination [121]: the
breasts’ lesions may appear as heterogeneous, hypoechoic, irregularly or ill-bordered masses
of different sizes, but usually small sizes, with internal echoes or thick-walled cystic lesions,
some mass may present posterior acoustic enhancement, in association to the fistula formation,
and the thickening of Cooper’s ligaments and subcutaneous tissues, as it was revealed in the
Romanian case. On the other side, it is mentioned an unique finding strongly suggestive for
breast TB: the presence of a dense sinus tract connecting an ill-defined breast mass to localized
skin thickening and bulge [14].
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Regarding the vascularisation of the breast tubercular masses, the blood flow was not
observed within the lesions, while increased circumferential vascularization was seen in the
color Doppler ultrasound, and the spectral evaluation shows a low resistance monophasic flow
pattern [121].
5.5.3. Magnetic resonance imaging (MRI) for breast/cervix uteri tuberculosis diagnosis
If on recommend MRI imaging for breast TB, it is possible to detect parenchymal asymmetry
with enhancement, micro-abscesses, and peripherally enhanced masses. MRI may reveal
lymphadenopathy along the pelvic walls, with an abnormal signal to the entire body of the
uterus and sometimes when the entire uterus is infected by MbT, the endometrial cavity,
myometrium, and junctional zone could not be differentiated and thus the radiological appear-
ance was consistent with Asherman’s syndrome [77].
5.6. Antitubercular therapeutic test for rare location tuberculosis diagnosis
There are cases with pulmonary and extrapulmonary TB with negative molecular test—PCR
for MbT from clinical specimens or it is not possible to recommend and use the rapid very
efficient modern molecular NAA for detection of mycobacterial DNA or RNA directly from
the specimens as it was previously discussed. In countries with endemic TB, it is since long
time discussed and recently it is recalled an empirical antitubercular therapy even in the
absence of positive acid-fast bacilli, and without culture—positive results, or when it is the
suspicion of TB or when the “idiopathic” granulomatous mastitis is found and it is not
responding to metothrexate or corticosteroids [108, 117].
TB is considered to be actually under-diagnosed in Romania, and the Romanian health history
had a similar management in cases which are mentioned before, and in these conditions, the
final diagnosis of the case with primary recurrent non-gestational breast abscess was done
after the antitibercular” therapeutic” test, which was efficient after the first two months. More
details are in the subsection 8 on “Treatment”.
6. Differential diagnosis
6.1. Differentials for breast tuberculosis
The breast tuberculosis can be confused with breast carcinoma, specially in elder women [27,
28, 69, 124], who present an isolated ill defined, irregular, occasionally hard breast lump
without sinuses/fistula, but pain is present more frequently in the tuberculous lump than in
carcinoma. Involvement of the nipple and areola is rare in tuberculosis, but fixation of the
lump to the skin may be present as a part of the inflammatory process, which is present in both
pathological entities A high index of suspicion needs to be maintained if a breast lump is
associated with a sinus or indolent lump in an immigrant women if this is encountered in the
western countries. The coexistence of tubercular axillary lymphadenitis with breast carcinoma
can falsely over-stage the disease [125], and is reported an association of the metastasis of
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breast carcinoma and axillary tuberculous lymphadenitis [126]. In postmenopausal women is
considered that the diagnosis of breast TB does not exclude a concomitent cancer [3], situation
that was first reported by Pilliet and Piatot in (cited by [27]).
In cases with discharging sinuses associated to a breast lump it is necessary to make the
differentiation from actinomycosis by the absence of sulfur granules in the discharge and by
fungal culture [9].
For women from countries with endemic tuberculosis from Asia and Africa, or immigrated
from that countries, the association of breast carcinoma and tuberculosis must be thought,
specially when the data are confusing [3, 127, 128], as it is when on records tuberculosis of
axillary lymph nodes with primary breast cancer [129], or axillary lymph nodes with granulo-
mas and a breast carcinoma [72, 130].
Beside carcinoma there are other misdiagnosis risks as “idiopathic” granulomatous mastitis
(Table 2, for pathological differential), or plasma cell mastitis (which may mimic histological
the tuberculosis by the presence of foreign body giant cells, epithelioid cells which are
arranged in tubercles, besides plasma cells, polymorphs, lymphocytes and few foamy macro-
phages, but is missing the caseation which makes the differential from tuberculosis- [131],
lupus mastitis [132], eritema nodosus [133].
In the last years there are described recurrent breast abscess to be more frequent due to non-
tuberculous mycobacterial infection [20, 134], cases with similar clinical presentation, with
granulomas.
6.2. Differentials for cervix uteri tuberculosis
When women’s complaints are present, and cervical examination shows cervical changes it
is considered to think about both pathologies, separately or associated in countries with
high risks for these pathologies. There are discussed other viral cervical infections as HIV,
herpes virus simplex, other sexual transmitted (Treponema pallidum, Trichomonas vaginalis,
Neisseria gonorrhea) or parasitic diseases as schistosomal, amoebic, brucella, tularaemia
which may induce chronic cervical granulomas, sarcoidosis, and foreign body reaction [77],
or more rare an epithelioid granulomas in Hodgkin’s disease [39].
7. Complications of breast/cervix uteri tuberculosis
When not adequate treated, TB mastitis is followed by abscesses, which can penetrate the
retromammary space [135], or to the ribs [136], formation of sinuses, and nipple retraction,
and irreversible inversion, recurrences even with surgical drainage/excision, and breast muti-
lation [26].
In the case with the association of two severe immunosuppressive diseases as tuberculosis and
cancer there are risks for reactivating the lung tuberculosis, for lung metastases from cervical
cancer, and of high mortality in patients with coexistent disease [137, 138].
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8. Treatment of breast/cervix uteri tuberculosis
Treatment may cure the disease with antitubercular drugs, and surgery is rarely required,
being used in cases resistant to medical treatment. The specific antitubercular treatment was
delayed in the Romanian case with breast abscess as is frequently mentioned in literature [24],
because the difficulties of the positive and differential diagnosis, and because tuberculosis is
under-diagnosis in contemporary Romania, but the attitude regarding tuberculosis was simi-
lar in the Romanian health history to that from tuberculosis endemic countries: to recommend
empirical antitubercular therapy even in the absence of positive AFB, and without positive
culture results, when it is a suspicion of TB or when the granuloma is found. In many cases, the
decision for the antitubercular treatment is taken after the failure of corticoids and methotrex-
ate therapy for “idiopathic” granulomatous mastitis [108, 117, 139].
Based on patient profile, clinical features and lack of response to usual antibiotic therapy, it is
recommended a four-drug (isoniazid, rifampin, ethambutol and pyrazinamide) 6-month course of
Directly Observed Therapy Short-Term (DOTS) - Category I [117], but the response to treatment is
variable and not dramatic. There are reported excellent results with such management [101].
There are no specific available guidelines for chemotherapy of breast TB, and the therapy
generally follows guidelines that are used for pulmonary TB. The regimen consists of a 2
month intensive phase (isoniazid, rifampicin, pyrazinamide and ethambutol), followed by a 4
month continuation phase (isoniazid and rifampin). It is recommended another regimen with
extension of continuation therapy for a longer period to 7 months [9, 140–142] or more up to
12–18 months [140], because the wish to lower the relapse rate. There is also a regimen which
combines first and second lines antitubercular drugs, including kanamycin, ofloxacin, ethion-
amide, para-amino salicylic acid (PAS), pyrazinamide and isoniazid, with the reason of the
risk of multidrug resistant strains [143]. The breast lesions and tenderness are steadily
improved after 2 months of intensive therapy the breast lesions and tenderness are steadily
improved [83] (Table 3).
Treatment duration Initial phase treatment (intensive therapy) Continuation treatment
6 months* 2 months of:
300 mg isoniazid,
600 mg rifampin,
1500 mg pyrazinamide,
1000 mg ethambutol or
streptomycin 1 g per day
4 months of isoniazid, rifampin
9 months** 2 months of:
300 mg isoniazid,
600 mg rifampin,
1500 mg pyrazinamide,
1000 mg ethambutol
per day
7 months of isoniazid, rifampin
*Al-Marri et al. [122]; Jalali et al. [102]; Mirsaeidi et al. [6], Bahoroon [107]; Gon et al. [28]; Singal, et al. [13].
**Daali et al. [141]; Khanna et al. [9]; Kumar et al. [143].
Table 3. Breast antitubercular regimens.
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In the Romanian primary recurrent non-gestational breast abscess was recalled as the old
concept of the “antitubercular therapeutic” test, for the final diagnosis and it was proved to
be efficient after the first 2 months, and the association of isoniazid and rifampin was contin-
ued with excellent results up to 9 months.
Surgery was imposed in the Romanian case because of abscess complications in the conditions
of MbT late diagnosis. It was a minimal surgical intervention required for drainage and
excision biopsy of abscesses’ wall. Surgery is commonly reserved for selected cases, in partic-
ular situations, and in different manner:
• According to the presence of breast masses/lump and abscesses with fistula: simple
or segmental mastectomy or quadrantectomy or drainage of abscess with large excision
of the necrotic tissue of the breast and excision of the axillary lymph nodes when
involved [25].
• Breast abscesses with negative bacteriological tests in order to diagnose by excision biopsy
of the abscess wall and drainage of abscess with fistula [16, 21, 67].
• In cases refractory to medication [69].
• Residual lumps after antitubercular therapy, excision of sinus [9, 10].
• Mastectomy when is severe breast destruction [14].
A special mention is for the percutaneous treatment with drainage controlled by CT and
specific antibiotic antitubercular drugs [123], especially when resistance to ATT is discovered
[144], as it is done for pulmonary TB and for abdominal collections [145].
The ATT are usually recommended for cervix uteri tuberculosis for minimum 6 months
[146], healing being proved by repeated biopsy. The chemo and radiotherapy, and the
radical surgical intervention done in the Romanian case were imposed by the initial
diagnosis of squamous non-keratinized cervical carcinoma stage IB, tubercular cervicitis
being a postoperative surprise, and it was decided to avoid a new cure of AAT because
the postoperative assessments for MbT lung or general reactivation were negative.
9. Conclusions
• Breast tuberculosis should be considered as a differential diagnosis of breast inflamma-
tory disease or masses, all over the world, not only where tuberculosis is endemic.
• Tuberculosis must be suspected in recurrent breast inflammatory disease with nega-
tive current cultures, and negative tests as Ziehl-Neelsen stain, culture and PCR for
MbT.
• The pathologic examination of the open biopsy in the reported case is suggesting the
diagnosis of a granulomatous mastitis, and the multinuclear giant cells of Langhans type
presence ensure the diagnosis of tubercular granulomatous mastitis even in the absence of
the characteristic caseous necrosis.
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• The final diagnosis of breast TB was established by specific antitubercular drugs, which
represents a Tuberculosis Diagnosis Test, and may avoid or delay breast characteristic muti-
lations when treatment is not adequate.
• The cervix uteri tuberculosis presence and its association to ecto/endocervical cancer is to
be suspected not only in developing countries with endemic tuberculosis and high rates of
HPV/HIV infections, in patients with primary lung/other organs tuberculosis.
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